Features of drug-drug interactions rivaroxaban and calcium channel blockers depending on the ABCB1 genotype (rs1045642 and rs4148738) in patients 80 years of age and older with non-valvular atrial fibrillation

Background. The use of P-glycoprotein (P-gp) inhibitors and carriage of certain ABCB1 polymorphisms can lead to increased concentrations of rivaroxaban and the development of bleeding.The aim of the study. To study the features of drug-drug interactions (DDI) of rivaroxaban in patients over 80 years...

全面介紹

書目詳細資料

發表在:	Acta Biomedica Scientifica
Main Authors:	D. A. Sychev, K. B. Mirzaev, M. S. Cherniaeva, N. V. Shakhgildyan, Sh. P. Abdullaev, N. P. Denisenko, Zh. A. Sozaeva, A. A. Kachanova, V. R. Shastina, S. V. Gorbatenkova
格式:	Article
語言:	俄语
出版:	Scientific Сentre for Family Health and Human Reproduction Problems 2024-01-01
主題:	drug-drug interactions rivaroxaban verapamil abcb1 (rs1045642 and rs4148738) therapeutic drug monitoring older patients
在線閱讀:	https://www.actabiomedica.ru/jour/article/view/4493